RARA CRAFT DATABASE for FDA Medical Devices
510(k)K163418

FDA DEVICE FACTS

Diazyme DZ-Lite Total beta-hCG Test System

Diazyme Laboratories

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 18, 2017PRODUCT CODEDHA

Indications for use

The Diazyme DZ-Lite Total βhCG Test System is comprised of the DZ-Lite Total βhCG assay, calibrator set and control set, using a paramagnetic particle, chemiluminescent immunoassay test method. The test system is intended for in vitro diagnostic use on Diazyme Chemiluminescent Analyzers for the quantitative determination of total beta-human chorionic gonadotropin (total βhCG) in human serum. The test system is intended for use as an aid in the early detection of pregnancy. The Diazyme DZ-Lite 3000 Plus Chemiluminescent Analyzer is intended for determination of various analyte concentrations in human specimens, and is intended for in vitro diagnostic use in a clinical laboratory.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 29, 2026